SEC Form 4 · accession 0001013606-17-000099
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | A | 48,222 | $0.00 | A | 797,169 | D | |
| Common StockF2 | Jun 1, 2017 | F | 5,821 | $4.79 | D | 791,348 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on June 1, 2015. 33% percent of the shares subject to this restricted stock award vested pursuant the terms of this award.
- F2Shares sold on June 1, 2017 to satisfy statutory minimum tax withholding obligations related to shares vested on May 28, 2017.